SMS Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SMS Pharmaceuticals has informed the exchanges that the trading window for its shares will remain closed from July 1, 2025, until 48 hours after the declaration of Q1 FY26 financial results (for the quarter ended June 30, 2025). This applies to all designated persons and their immediate relatives, as per SEBI's Insider Trading Regulations, 2015 and the company's own Code of Conduct. The company has not yet announced the date of the board meeting to consider the Q1 results, but it will be communicated later. This is a routine compliance filing and does not involve any business decision or material event.
No direct impact on the stock price. It is a standard regulatory intimation that signals upcoming quarterly results, after which the trading window will reopen. Shareholders should expect Q1 FY26 results to be announced in the coming weeks.